Intellectia LogoIntellectia
Product
Resources
Stock
Crypto
Pricing
Sign inTry for Free
Intellectia Logo
Sign in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
Crypto Technical Analysis
AI Screener
Trading Strategy
AI Stock Picker
Swing Trading
Earnings Trading
Stock Chart Patterns

Resources

Learn
Blog
Earnings
Tutorial
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
StockCryptoPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. RPRX
    4. >
  4. Valuation

Valuation

-
stocks logo
RPRX
-
$
0.000
0.000(0.000%)
    OverviewForecastTechnicalOptionsEarningsFinancialsValuationInsiders

Is RPRX Overvalued？

RPRX is now in the zone, suggesting that RPRX current forward PE ratio of 7.02 is considered compare with the five-year average of 10.97.
P/E
EV/EBITDA
P/S
P/B
P/E
bubble
P/E

RPRX Competitors Valuation Multiple

P/E
EV/EBITDA
P/S
P/E

P/E Multiple

Earnings Growth
Market Cap
stocks logo
RPRX.O
Royalty Pharma PLC
7.02
Average P/E: 99.65
-57.83%
18.89B
stocks logo
BIIB.O
Biogen Inc
8.80
Average P/E: 99.65
6.81%
20.41B
stocks logo
HCM.O
HUTCHMED (China) Ltd
67.66
Average P/E: 99.65
13.68B
stocks logo
UTHR.O
United Therapeutics Corp
11.27
Average P/E: 99.65
43.08%
13.80B
stocks logo
ITCI.O
Intra-Cellular Therapies Inc
491.61
Average P/E: 99.65
46.39%
13.96B
stocks logo
INCY.O
Incyte Corp
11.53
Average P/E: 99.65
9.55%
13.13B

RPRX Revenue Breakdown & PS Ratio Relation

Currency:USD
By Business
By Region
Composition ()
Name
Revenue
Percentage

RPRX FAQs

Is RPRX currently overvalued based on its P/E ratio?

According to the provided data, RPRX's 5-year historical average forward P/E ratio is 10.97. RPRX forward P/E ratio is 7.02, which is categorized as Undervalued.

How has RPRX's P/E ratio changed over the quarters?

The P/E ratio has shown significant fluctuations, with a notable increase from 11.11 to 13.34, indicating changes in market expectations and earnings.

What is the significance of the EV/EBITDA ratio for RPRX?

The EV/EBITDA ratio helps assess the company's valuation relative to its earnings before interest, taxes, depreciation, and amortization, providing a clearer picture of its operating performance.

How has RPRX's Price to Sales (PS) ratio evolved?

The PS ratio decreased from 7.44 to 6.70, reflecting changes in the company's revenue relative to its market capitalization.

What are the key indicators to watch for RPRX's financial performance?

Key indicators include valuation ratios (P/E, EV/EBITDA, P/FCF), revenue growth, and profitability metrics to assess overall financial health.

RPRX PE Ratio

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalued
5Y Average PE
10.97
Current PE
7.02
Overvalued PE
14.62
Undervalued PE
7.33

RPRX EV/EBITDA Ratio

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalued
5Y Average EV
10.90
Current EV
8.50
Overvalued EV
13.15
Undervalued EV
8.65

RPRX P/S Ratio

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalued
5Y Average PS
6.27
Current PS
4.81
Overvalued PS
7.70
Undervalued PS
4.84

RPRX Competitors Valuation Multiple

P/E
EV/EBITDA
P/S
P/E

P/E Multiple

Earnings Growth
Market Cap
stocks logo
RPRX.O
Royalty Pharma PLC
7.02
Average P/E: 99.65
-57.83%
18.89B
stocks logo
BIIB.O
Biogen Inc
8.80
Average P/E: 99.65
6.81%
20.41B
stocks logo
HCM.O
HUTCHMED (China) Ltd
67.66
Average P/E: 99.65
13.68B
stocks logo
UTHR.O
United Therapeutics Corp
11.27
Average P/E: 99.65
43.08%
13.80B
stocks logo
ITCI.O
Intra-Cellular Therapies Inc
491.61
Average P/E: 99.65
46.39%
13.96B
stocks logo
INCY.O
Incyte Corp
11.53
Average P/E: 99.65
9.55%
13.13B

RPRX Revenue Breakdown & PS Ratio Relation

Currency:USD
By Business
By Region
Composition ()
Name
Revenue
Percentage

Free Financial AI Agent for Investment

Ask any investment related question and get answer instantly

At what price is RPRX undervalued？Is RPRX overvalued compared to its competitors？

RPRX FAQs

Is RPRX currently overvalued based on its P/E ratio?

According to the provided data, RPRX's 5-year historical average forward P/E ratio is 10.97. RPRX forward P/E ratio is 7.02, which is categorized as Undervalued.

How has RPRX's P/E ratio changed over the quarters?

The P/E ratio has shown significant fluctuations, with a notable increase from 11.11 to 13.34, indicating changes in market expectations and earnings.

What is the significance of the EV/EBITDA ratio for RPRX?

The EV/EBITDA ratio helps assess the company's valuation relative to its earnings before interest, taxes, depreciation, and amortization, providing a clearer picture of its operating performance.

How has RPRX's Price to Sales (PS) ratio evolved?

The PS ratio decreased from 7.44 to 6.70, reflecting changes in the company's revenue relative to its market capitalization.

What are the key indicators to watch for RPRX's financial performance?

Key indicators include valuation ratios (P/E, EV/EBITDA, P/FCF), revenue growth, and profitability metrics to assess overall financial health.

Free Financial AI Agent for Investment

Ask any investment related question and get answer instantly

At what price is RPRX undervalued？Is RPRX overvalued compared to its competitors？
Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerCrypto Technical AnalysisAI Screener
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings Trading
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySitemap
Start for Free